617
Views
60
CrossRef citations to date
0
Altmetric
Original Article

Effects of particle size and coating on toxicologic parameters, fecal elimination kinetics and tissue distribution of acutely ingested silver nanoparticles in a mouse model

, , , , , , , , , , & show all
Pages 352-360 | Received 05 Apr 2015, Accepted 10 Jul 2015, Published online: 24 Aug 2015

References

  • Ahmadi F, Kordestany AH. 2011. Investigation on silver retention in different organs and oxidative stress enzymes in male broilers fed diet supplemented with powder of nano silver. Am-Eur J Toxicol Sci 3:28–35
  • Ahmadi F, Kurdestany AH. 2010. The impact of silver nano particles on growth performance, lymphoid organs, and oxidative stress indicators in broiler chicks. Global Vet 5:366–70
  • Ahmadi F, Rahimi F. 2011. The effect of different levels of nano silver and retention of silver in edible tissues of broilers. World Appl Sci J 12:01–4
  • Albanese A, Tang PS, Chan WCW. 2012. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng 14:1–16
  • Antonopoulos DA, Huse SM, Morrison HG, Schmidt TM, Sogin ML, Young VB. 2009. Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun 77:2367–75
  • ATSDR. 1990. Toxicological profile for silver. Atlanta, GA: Agency for Toxic Substances and Disease Registry, U.S. Department of Health and Human Services, Public Health Service. Available at: http://www.atsdr.cdc.gov. Accessed on 15 June 2015
  • Axson JL, Stark DI, Bondy A, Capracotta SS, Maynard AD, Philbert, MA, et al. Rapid kinetics of size and pH-dependent dissolution and aggregation of silver nanoparticles in simulated gastric fluid. J Phys Chem, in press
  • Behra R, Sigg L, Clift MJ, Herzog F, Minghetti M, Johnston B, et al. 2013. Bioavailability of silver nanoparticles and ions: from a chemical and biochemical perspective. J R Soc Interface 10:20130396
  • Bergin IL, Witzmann FA. 2013. Nanoparticle toxicity by the gastrointestinal route: evidence and knowledge gaps. Int J Biomed Nanosci Nanotechnol 3:163–210
  • Bowden LP, Royer MC, Hallman JR, Lewin-Smith M, Lupton GP. 2011. Rapid onset of argyria induced by a silver-containing dietary supplement. J Cutan Pathol 38:832–5
  • Brandt D, Park B, Hoang M, Jacobe HT. 2005. Argyria secondary to ingestion of homemade silver solution. J Am Acad Dermatol 53:S105–7
  • Cha KE, Myung H. 2007. Cytotoxic effects of nanoparticles assessed both in vitro and in vivo. J Microbiol Biotechnol 17:1573–8
  • Chung IS, Lee MY, Shin DH, Jung HR. 2010. Three systemic argyria cases after ingestion of colloidal silver solution. Int J Dermatol 49:1175–7
  • Dehner CA, Barton L, Maurice PA, Dubois JL. 2011. Size-dependent bioavailability of hematite (alpha-Fe2O3) nanoparticles to a common aerobic bacterium. Environ Sci Technol 45:977–83
  • Drake PL, Hazelwood KJ. 2005. Exposure-related health effects of silver and silver compounds: a review. Ann Occup Hyg 49:575–85
  • Fondevila M, Herrer R, Casallas MC, Abecia L, Ducha JJ. 2009. Silver nanoparticles as a potential antimicrobial additive for weaned pigs. Anim Feed Sci Technol 150:259–69
  • Hadrup N, Lam HR. 2014. Oral toxicity of silver ions, silver nanoparticles and colloidal silver – a review. Regul Toxicol Pharmacol 68:1–7
  • Hadrup N, Loeschner K, Bergstrom A, Wilcks A, Gao X, Vogel U, et al. 2012. Subacute oral toxicity investigation of nanoparticulate and ionic silver in rats. Arch Toxicol 86:543–51
  • Hamilton RF, Buckingham S, Holian A. 2014. The effect of size on Ag nanosphere toxicity in macrophage cell models and lung epithelial cell lines is dependent on particle dissolution. Int J Mol Sci 15:6815–30
  • Hillyer JF, Albrecht RM. 2001. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J Pharm Sci 90:1927–36
  • Huynh KA, Chen KL. 2011. Aggregation kinetics of citrate and polyvinylpyrrolidone coated silver nanoparticles in monovalent and divalent electrolyte solutions. Environ Sci Technol 45:55564–71
  • Kim Y, Suh HS, Cha HJ, Kim SH, Jeong KS, Kim DH. 2009. A case of generalized argyria after ingestion of colloidal silver solution. Am J Ind Med 52:246–50
  • Kim YS, Song MY, Park JD, Song KS, Ryu HR, Chung YH, et al. 2010. Subchronic oral toxicity of silver nanoparticles. Particle Fibre Toxicol 7:20
  • Lansdown AB. 2010. A pharmacological and toxicological profile of silver as an antimicrobial agent. Adv Pharmacol Sci 2010:910686. doi: 10.1155/2010/910686
  • Liu JY, Wang ZY, Liu FD, Kane AB, Hurt RH. 2012. Chemical transformations of nanosilver in biological environments. Acs Nano 6:9887–99
  • Loeschner K, Hadrup N, Qvortrup K, Larsen A, Gao XY, Vogel U, et al. 2011. Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Particle Fibre Toxicol 8. Available at: <Go to ISI>://WOS:000292207000001. Accessed on June
  • Maneewattanapinyo P, Banlunara W, Thammacharoen C, Ekgasit S, Kaewamatawong T. 2011. An evaluation of acute toxicity of colloidal silver nanoparticles. J Vet Med Sci 73:1417–23
  • McQuillan JS, Infante HG, Stokes E, Shaw AM. 2012. Silver nanoparticle enhanced silver ion stress response in Escherichia coli K12. Nanotoxicology 6:857–66
  • Mirsattari SM, Hammond RR, Sharpe MD, Leung FY, Young GB. 2004. Myoclonic status epilepticus following repeated oral ingestion of colloidal silver. Neurology 62:1408–10
  • Morones-Ramirez J, Winkler J, Spina C, Collins J. 2013. Silver enhances antibiotic activity against gram-negative bacteria. Sci Transl Med 5. doi: 10.1126/scitranslmed.3006276
  • Morrill K, May K, Leek D, Langland N, Jeane LD, Ventura J, et al. 2013. Spectrum of antimicrobial activity associated with ionic colloidal silver. J Altern Complement Med 19:224–31
  • Munger MA, Hadlock G, Stoddard G, Slawson MH, Wilkins DG, Cox N, Rollins D. 2015. Assessing orally bioavailable commercial silver nanoparticle product on human cytochrome P450 enzyme activity. Nanotoxicology 9:474–81
  • Munger MA, Radwanski P, Hadlock GC, Stoddard G, Shaaban A, Falconer J, et al. 2014. In vivo human time-exposure study of orally dosed commercial silver nanoparticles. Nanomedicine 10:1–9
  • Nowack B, Krug HF, Height M. 2011. 120 years of nanosilver history: implications for policy makers. Environ Sci Technol 45:1177–83
  • O’Brien N, Cummins E. 2010. Ranking initial environmental and human health risk resulting from environmentally relevant nanomaterials. J Environ Sci Health A Tox Hazard Subst Environ Eng 45:992–1007
  • Ohbo Y, Fukuzako H, Takeuchi K, Takigawa M. 1996. Argyria and convulsive seizures caused by ingestion of silver in a patient with schizophrenia. Psychiatry Clin Neurosci 50:89–90
  • Park EJ, Bae E, Yi J, Kim Y, Choi K, Lee SH, et al. 2010. Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles. Environ Toxicol Pharmacol 30:162–8
  • Park K, Park EJ, Chun IK, Choi K, Lee SH, Yoon J, Lee BC. 2011. Bioavailability and toxicokinetics of citrate-coated silver nanoparticles in rats. Arch Pharm Res 34:153–8
  • Poitras EP, Levine MA, Harrington JM, Essader AS, Fennell TR, Snyder RW, et al. 2015. Development of an analytical method for assessment of silver nanoparticle content in biological matrices by inductively coupled plasma mass spectrometry. Biol Trace Elem Res 163:184–92
  • Seth D, Choudhury SR, Pradhan S, Gupta S, Palit D, Das S, et al. 2011. Nature-inspired novel drug design paradigm using nanosilver: efficacy on multi-drug-resistant clinical isolates of tuberculosis. Curr Microbiol 62:715–26
  • Sharma VK, Siskova KM, Zboril R, Gardea-Torresdey JL. 2014. Organic-coated silver nanoparticles in biological and environmental conditions: fate, stability and toxicity. Adv Colloid Interface Sci 204:15–34
  • Shaw BJ, Handy RD. 2011. Physiological effects of nanoparticles on fish: a comparison of nanometals versus metal ions. Environ Int 37:1083–97
  • Tejamaya M, Romer I, Merrifield RC, Lead JR. 2012. Stability of citrate, PVP, and PEG coated silver nanoparticles in ecotoxicology media. Environ Sci Technol 46:7011–17
  • Theriot CM, Koenigsknecht MJ, Carlson PE Jr, Hatton GE, Nelson AM, Li B, et al. 2014. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat Commun 5:3114
  • Thoolen B, Maronpot RR, Harada T, Nyska A, Rousseaux C, Nolte T, et al. 2010. Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system. Toxicol Pathol 38:5S–81S
  • U.S. Code. 2011. Title 15, Chapter 53 Toxic Substances Control. Sec 2602 (2) (A). Available from: http://uscode.house.gov
  • U.S. EPA. 1996. Integrated Risk Information System (IRIS) Toxicological Review and Summary documents for silver, CASRN 7440-22-4. Washington, D.C.: U.S. Environmental Protection Agency. Available at: http://www.epa.gov/iris/index.html. Accessed on 15 June 2015
  • van der Zande M, Vandebriel RJ, van Doren E, Kramer E, Herrera Rivera Z, Serrano-Rojero CS, et al. 2012. Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. ACS Nano 6:7427–42
  • Varner KE, el-Badawy A, Feldhake D, Venkatapathy R. 2010. State-of-the-science review: everything nanosilver and more. EPA/600/R-10/084. Washington, DC: U.S. Environmental Protection Agency
  • Volker C, Oetken M, Oehlmann J. 2013. The biological effects and possible modes of action of nanosilver. Rev Environ Contam Toxicol 223:81–106
  • Wadhera A, Fung M. 2005. Systemic argyria associated with ingestion of colloidal silver. Dermatol Online J 11:2
  • Walters CR, Pool EJ, Somerset VS. 2014. Ecotoxicity of silver nanomaterials in the aquatic environment: a review of literature and gaps in nano-toxicological research. J Environ Sci Health A Tox Hazard Subst Environ Eng 49:1588–601
  • Wang X, Ji ZX, Chang CH, Zhang HY, Wang MY, Liao YP, et al. 2014. Use of coated silver nanoparticles to understand the relationship of particle dissolution and bioavailability to cell and lung toxicological potential. Small 10:385–98
  • Wijnhoven SWP, Peijnenburg W, Herberts CA, Hagens WI, Oomen AG, Heugens EHW, et al. 2009. Nano-silver – a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology 3:109–U78
  • Yin Win K, Feng S-S. 2005. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 26:2713–22
  • Zarei M, Jamnejad A, Khajehali E. 2014. Antibacterial effect of silver nanoparticles against four foodborne pathogens. Jundishapur J Microbiol 7:e8720

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.